Media Pack
News

Current Edition

JCS Volume 15 Issue 3
 
Europe

Aeromics Initiates Phase 1 Clinical Trial Of CNS Edema Inhibitor AER-271 In Healthy Human Volunteers

Aeromics, Inc. ("Aeromics" or "the Company"), a privately-held, clinical-stage pharmaceutical company focused on controlling cerebral edema for people affected by dis...
11 July 2018 Europe Aeromics | clinical
Continue Reading →
Europe

After failure, Zynerba shifts gears to save cash

Zynerba Pharmaceuticals on Thursday announced negative topline results from a Phase 1 safety and dosing study of its transdermal tetrahydrocannabinol patch ZYN001,...
11 July 2018 Europe cash | failure
Continue Reading →
Australasia

First Volunteers Dosed in Phase I Clinical Trial of PBT434, Prana’s Lead Therapy for Parkinsonian Diseases

Prana enrols and doses its first cohort of healthy volunteers in its Phase I clinical trial Evidence supports activity of PBT434 to prevent α-synuclein accumulat...
4 July 2018 Australasia | Europe | North America clinical | dosed
Continue Reading →
Europe

Helperby Therapeutics announces phase 1 results demonstrating multiple benefits of its unique combination antibiotic therapy – effective against the WHO Critical Priority Carbapenem resistant bacterial pathogens

The combination is azidothymidine (AZT), which is a new class antibacterial, and low dose colistin. The combination is active against all three WHO Critical Priori...
19 April 2018 Europe clinical | Helperby
Continue Reading →
Europe

Treos Bio Announces Activation of U.S. Clinical Trial Site for Phase 1 Study of PolyPEPI™ Precision Cancer Vaccine for Patients with Metastatic Colorectal Cancer

Treos Bio Limited, an immuno-oncology company developing next-generation, off-the-shelf precision cancer vaccines coupled with companion diagnostics, today said it ha...
11 April 2018 Europe | North America | Uncategorized activation | bio
Continue Reading →
Europe

miRagen Announces Initiation of Phase 1 Clinical Trial of MRG-110

miRagen Therapeutics, Inc, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today the initiati...
28 March 2018 Europe | North America clinical | miRagen
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2023, All Rights Reserved – Powered by Teksyte